July 1, 2026 marks an exciting milestone for GenDx, our customers, and the global transplant community. Following Eurobio Scientific’s acquisition of the CareDx Lab Products, the CareDx Lab Products portfolio is now officially becoming part of GenDx. By integrating these highly complementary product portfolios, we are creating one of the most comprehensive offerings in molecular transplant diagnostics.

This is more than an acquisition. It is a strategic step that strengthens our ability to support transplant laboratories with innovative solutions across the entire transplantation workflow, from pre-transplant HLA typing to post-transplant monitoring.

A broader portfolio, designed around your laboratory

By combining CareDx’s trusted HLA typing technologies with GenDx’s leading next-generation sequencing (NGS) assays, software, and analysis solutions, laboratories now have access to a more complete portfolio from a single partner.

Together, our portfolio now includes:

  • HLA typing solutions based on NGS and real-time PCR
  • High-resolution HLA sequencing assays
  • Analysis software and workflow solutions
  • Products supporting transplantation monitoring
  • Education, training, and scientific support

Whether your laboratory performs routine HLA typing, high-resolution sequencing, or advanced transplantation diagnostics, our expanded portfolio offers greater flexibility to meet your evolving needs.

Stronger together

By bringing together the strengths of GenDx and CareDx Lab Products, we are strengthening our ability to support transplant laboratories worldwide. With an expanded commercial presence across Europe, the United States, and Asia-Pacific, customers will benefit from faster access to products, enhanced local sales and technical support, and a consistent, high-quality customer experience. At the same time, the combination of our complementary expertise in high-resolution HLA typing, hybrid capture technologies, transplantation monitoring, and software development will accelerate innovation and expand our portfolio of molecular diagnostic solutions. Together with strengthened manufacturing and supply chain capabilities, this enables us to improve product availability and delivery reliability while continuing to provide the scientific expertise, responsive support, and reliable solutions that laboratories need to deliver the best possible outcomes for transplant patients.

Business continues as usual

For existing GenDx and CareDx Lab Products customers, business will continue as usual. There will be no disruption to products, services, customer support, or ongoing activities. Over the coming period, CareDx Lab Products will be fully integrated into the GenDx brand, while maintaining the quality, expertise, and customer focus you know and trust. The existing sales and support contacts will remain available throughout this transition.

Looking ahead

This milestone represents an important step in GenDx’s mission to advance molecular transplant diagnostics through innovation, scientific excellence, and close collaboration with laboratories around the world.

We are excited about the opportunities this brings—not only for our organization, but more importantly for the transplant community we serve.

Together, we look forward to continuing to support laboratories with comprehensive solutions that help improve the quality of life and survival of transplant patients.

Welcome to this new chapter. Together, we are shaping the future of transplant diagnostics.